Advisornet Financial’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Advisornet Financial's CRL Position: Q2 2026 in Review
Advisornet Financial held its Charles River Laboratories (CRL) position steady in Q2 2026 at 55 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1522.
Advisornet Financial first reported a position in CRL in Q2 2018 and has held it in 21 quarters since. The position peaked at $32.2K in Q1 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Advisornet Financial held 55 shares of Charles River Laboratories worth $12.5K as of Q2 2026.
- Advisornet Financial left its Charles River Laboratories share count unchanged in Q2 2026.
- Charles River Laboratories made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1522 holding.
- Advisornet Financial first reported a position in Charles River Laboratories in Q2 2018 and has held it in 21 quarters since.
- Advisornet Financial's Charles River Laboratories position peaked at $32.2K in Q1 2024.
- 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.